FRESENIUS MEDICAL CARE AG
DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Article 5 (1) (b), (3) of Regulation (EU) No 596/2014 and Article 2 (3) of Delegated Regulation (EU) No 2016/1052 Announcement pursuant to Article 5 (1) (b), (3) of Regulation (EU) No 596/2014 and Article 2 (3) of Delegated Regulation (EU) No 2016/1052 - Share buy-back - 1st Interim Report In the period from 11 December 2017 until and including 15 December 2017, a total of 438,575 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care'), which was announced on 8 December 2017 pursuant to Article 5 (1) (a) of Regulation (EU) No 596/2014 and Article 2 (1) of Delegated Regulation (EU) No 2016/1052.
The total volume of shares repurchased within the framework of this share buy-back in the period from 11 December until and including 15 December 2017 therefore amounts to 438,575 shares. The purchase of shares of Fresenius Medical Care within the framework of the share buy-back programme was carried out exclusively on the Frankfurt Stock Exchange via the XETRA trading platform by a credit institution commissioned by Fresenius Medical Care. Detailed information on the transactions pursuant to Article 2 (3) of Delegated Regulation (EU) No 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., 18 December 2017
18.12.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |
640175 18.12.2017
